Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.
Stefania Infante M, Fernández-Cruz A, Núñez L, Carpio C, Jiménez-Ubieto A, López-Jiménez J, Vásquez L, Del Campo R, Romero S, Alonso C, Morillo D, Prat M, Luis Plana J, Villafuerte P, Bastidas G, Bocanegra A, Serna Á, De Nicolás R, Marquet J, Mas-Ochoa C, Cordoba R, García-Suárez J, Comai A, Martín X, Bastos-Oreiro M, Seri C, Navarro-Matilla B, López-Guillermo A, Martínez-López J, Ángel Hernández-Rivas J, Ruiz-Camps I, Grande C; Grupo Español de Linfomas y Trasplante Autólogo de Medula Ósea (GELTAMO). Stefania Infante M, et al. Cancer Med. 2021 Nov;10(21):7629-7640. doi: 10.1002/cam4.4293. Epub 2021 Sep 23. Cancer Med. 2021. PMID: 34558211 Free PMC article.
Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
Bouza E, Valerio M, Soriano A, Morata L, Carus EG, Rodríguez-González C, Hidalgo-Tenorio MC, Plata A, Muñoz P, Vena A; DALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España). Bouza E, et al. Int J Antimicrob Agents. 2018 Apr;51(4):571-577. doi: 10.1016/j.ijantimicag.2017.11.008. Epub 2017 Nov 24. Int J Antimicrob Agents. 2018. PMID: 29180276
Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies.
Calderón-Parra J, Múñez-Rubio E, Fernández-Cruz A, García-Sánchez MC, Maderuelo-González E, López-Dosil M, Calvo-Salvador M, Baños-Pérez I, Valle-Falcones M, Ramos-Martínez A. Calderón-Parra J, et al. Clin Infect Dis. 2022 May 30;74(10):1786-1794. doi: 10.1093/cid/ciab700. Clin Infect Dis. 2022. PMID: 34383032
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Rubio-Rivas M, Mora-Luján JM, Montero A, Aguilar García JA, Méndez Bailón M, Fernández Cruz A, Oriol I, Teigell-Muñoz FJ, Dendariena Borque B, De la Peña Fernández A, Fernández González R, Gil Sánchez R, Fernández Fernández J, Catalán M, Cortés-Rodríguez B, Mella Pérez C, Montero Rivas L, Suárez Fuentetaja R, Ternero Vega JE, Ena J, Martin-Urda Díez-Canseco A, Pérez García C, Varona JF, Casas-Rojo JM, Millán Núñez-Cortés J; SEMI-COVID-19 Network. Rubio-Rivas M, et al. J Gen Intern Med. 2022 Jan;37(1):168-175. doi: 10.1007/s11606-021-07146-0. Epub 2021 Oct 18. J Gen Intern Med. 2022. PMID: 34664188 Free PMC article.
Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study.
Muñoz-Gómez A, Fernández-Cruz A, Lavilla-Olleros C, Giner-Galvañ V, Ausín-García C, Wikman P, Bendala-Estrada AD, Vargas JA, Rubio-Rivas M, Laureiro J, Fernández-Bermúdez D, Buonaiuto VA, Arenas de Larriva AP, Pascual-Pérez MLR, Alcalá-Pedrajas JN, Labirua-Iturburu Ruiz A, Hernández-Milián A, Gómez Del Mazo M, Antequera B, Mella-Pérez C, Navas-Alcántara MS, Soto-Delgado JF, Gámez-Mancera RM, Sardiña-González C, Meijide-Míguez H, Ramos-Rincón JM, Gómez-Huelgas R, On Behalf Of The Semi-Covid-Network. Muñoz-Gómez A, et al. J Clin Med. 2021 Oct 13;10(20):4678. doi: 10.3390/jcm10204678. J Clin Med. 2021. PMID: 34682801 Free PMC article.
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
Bergas A, Albasanz-Puig A, Fernández-Cruz A, Machado M, Novo A, van Duin D, Garcia-Vidal C, Hakki M, Ruiz-Camps I, Del Pozo JL, Oltolini C, DeVoe C, Drgona L, Gasch O, Mikulska M, Martín-Dávila P, Peghin M, Vázquez L, Laporte-Amargós J, Durà-Miralles X, Pallarès N, González-Barca E, Álvarez-Uría A, Puerta-Alcalde P, Aguilar-Company J, Carmona-Torre F, Clerici TD, Doernberg SB, Petrikova L, Capilla S, Magnasco L, Fortún J, Castaldo N, Carratalà J, Gudiol C. Bergas A, et al. Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27. Microbiol Spectr. 2022. PMID: 35475683 Free PMC article.
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort.
Calderón-Parra J, Guisado-Vasco P, Montejano-Sánchez R, Estrada V, Cuevas-Tascón G, Aguareles J, Arribas J, Erro-Iribarren M, Calvo-Salvador M, Fernández-Cruz A, Ramos-Martínez A, Muñez-Rubio E. Calderón-Parra J, et al. J Clin Med. 2023 Jan 21;12(3):864. doi: 10.3390/jcm12030864. J Clin Med. 2023. PMID: 36769511 Free PMC article.
344 results